近日,春立医疗披露2024年年度报告,业绩表现引发市场关注。报告显示,公司2024年度实现营业收入8.06亿元,较上一年度下滑33.32%;归属于上市公司股东的净利润为1.25亿元,同比大幅下降55.01%。在业绩承压的背后,公司管理层中一位27岁年轻女董事长的身影,成为市场热议的焦点。史文玲,女,汉族,1998年1月出生,中国国籍,无境外永久居留权。毕业于美国俄交俄州立大学,市场营销与运营管理...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.